Impressions of the 30th Brain Tumour Information Day
On Saturday, 28th April, the Deutsche Hirntumorhilfe organized the 30th German wide Information Day about the topic “Progress in the therapy of brain tumours”. Thererefore interested patients, relatives, and doctors had been invited to come from 9.30 am till 18.30 pm to the University of Würzburg. Under the direction of professor Ralf-Ingo Ernestus, the day offered a program with various lectures of high-quality referents. Recognized experts presented up to date knowledge as well as innovations in the treatment and the aftercare of brain tumours and brain metastases.
Professor Krauseneck: „Approved/new information about chemotherapy"
He has 40 years experience in neuro-oncology and is a founding member of NOA. The former head of the Department of Neurology Bamberg said: "Chemotherapy can only work if it is applied consistently, the NOA-01 trial had the best results. ACNU could be replaced by fotemustine. It's worthwhile to fight - but not at any price."
Professor Dr. Tonn: „Individual therapy of low grade gliomas"
The director of Neurosurgery at University Hospital in Munich Großhaderm informed: "You should never wait without histology. An anaplastic component must be detected as early as possible. Molecular markers are important for the diagnosis, prognosis and therapy for an individualized treatment for every patient."
Professor Dr. Wolfgang Wick: „Clinical Trials 2012: An Update“
The medical director of the Department of Neuro Oncology in Heidelberg annotated clinical trials in glioblastoma: eg CCI-779, bevacizumab, cilengitide, Rindopepimut, TMZ + CCNU, parvovirus and BIBF 1120. He sees clinical trials as an additional opportunity for the patient to get new and modern drugs as early as possible.
back to the main page of the Brain Tumour Information Day
